.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Medtronic
Federal Trade Commission
US Department of Justice
Johnson and Johnson
Chubb
Covington
AstraZeneca
Novartis
Cantor Fitzgerald

Generated: July 22, 2017

DrugPatentWatch Database Preview

CEFDINIR Drug Profile

« Back to Dashboard

What is the patent landscape for Cefdinir, and when can generic versions of Cefdinir launch?

Cefdinir is a drug marketed by Orchid Hlthcare, Sandoz, Teva Pharms, Aurobindo Pharma, and Lupin. and is included in ten NDAs.

The generic ingredient in CEFDINIR is cefdinir. There are twelve drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the cefdinir profile page.

Summary for Tradename: CEFDINIR

Patents:0
Applicants:5
NDAs:10
Suppliers / Packagers: see list27
Bulk Api Vendors: see list85
Clinical Trials: see list20
Patent Applications: see list2,819
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFDINIR at DailyMed

Pharmacology for Tradename: CEFDINIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare
CEFDINIR
cefdinir
CAPSULE;ORAL065418-001Jul 18, 2007ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
CEFDINIR
cefdinir
CAPSULE;ORAL065434-001Jan 7, 2008ABRXNoNo► Subscribe► Subscribe
Sandoz
CEFDINIR
cefdinir
CAPSULE;ORAL065330-001Apr 6, 2007ABRXNoYes► Subscribe► Subscribe
Lupin
CEFDINIR
cefdinir
CAPSULE;ORAL065264-001May 19, 2006ABRXNoNo► Subscribe► Subscribe
Sandoz
CEFDINIR
cefdinir
FOR SUSPENSION;ORAL065337-001Apr 6, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
US Army
Healthtrust
Chubb
McKinsey
Accenture
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot